Literature DB >> 24237695

Inflammasome-microbiota interplay in host physiologies.

Janelle S Ayres1.   

Abstract

Host defense responses against microbes are most often thought of in terms of effectors of microbial destruction. However, recent evidence demonstrates that the more complex interactions between the microbiota and innate immune mechanisms, such as the inflammasome-mediated response, cannot be readily explained within just the traditional paradigms of microbial killing mechanisms. In this review, the concepts of both resistance and tolerance are applied to inflammasome-microbiota interactions, and the various physiological consequences of this interplay, including roles in inflammation, tissue repair, tumorigenesis, and metabolism, are discussed.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24237695     DOI: 10.1016/j.chom.2013.10.013

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  20 in total

Review 1.  Genome-based nutrition: an intervention strategy for the prevention and treatment of obesity and nonalcoholic steatohepatitis.

Authors:  Sonia Roman; Claudia Ojeda-Granados; Omar Ramos-Lopez; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Interleukin-17A Aggravates Middle Ear Injury Induced by Streptococcus pneumoniae through the p38 Mitogen-Activated Protein Kinase Signaling Pathway.

Authors:  Wei Wang; Wenbin Liu; Jiali Liu; Zimeng Wang; Fangmei Fan; Yurong Ma; Chunfang Jin; Yun Xiang; Yifei Huang; Xuemei Zhang; Wenchun Xu; Yibing Yin; Yujuan He
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

Review 3.  Thermoregulation as a disease tolerance defense strategy.

Authors:  Alexandria M Palaferri Schieber; Janelle S Ayres
Journal:  Pathog Dis       Date:  2016-11-03       Impact factor: 3.166

Review 4.  Disease tolerance and immunity in host protection against infection.

Authors:  Miguel P Soares; Luis Teixeira; Luis F Moita
Journal:  Nat Rev Immunol       Date:  2017-01-03       Impact factor: 53.106

Review 5.  The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma.

Authors:  Marco Sanduzzi Zamparelli; Alba Rocco; Debora Compare; Gerardo Nardone
Journal:  United European Gastroenterol J       Date:  2017-05-08       Impact factor: 4.623

Review 6.  Microbiota as a mediator of cancer progression and therapy.

Authors:  Jillian L Pope; Sarah Tomkovich; Ye Yang; Christian Jobin
Journal:  Transl Res       Date:  2016-08-03       Impact factor: 7.012

7.  IL-1β and Inflammasome Activity Link Inflammation to Abnormal Fetal Airway Development.

Authors:  Ashley N Stouch; Alyssa M McCoy; Rachel M Greer; Omar Lakhdari; Fiona E Yull; Timothy S Blackwell; Hal M Hoffman; Lawrence S Prince
Journal:  J Immunol       Date:  2016-03-07       Impact factor: 5.422

8.  Chitinase 3-Like 1 (Chil1) Regulates Survival and Macrophage-Mediated Interleukin-1β and Tumor Necrosis Factor Alpha during Pseudomonas aeruginosa Pneumonia.

Authors:  Chad R Marion; Jianmiao Wang; Lokesh Sharma; Ashley Losier; Wei Lui; Nathaniel Andrews; Jack A Elias; Barbara I Kazmierczak; Craig R Roy; Charles S Dela Cruz
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

Review 9.  The Biology of Physiological Health.

Authors:  Janelle S Ayres
Journal:  Cell       Date:  2020-04-16       Impact factor: 41.582

Review 10.  Cooperative Microbial Tolerance Behaviors in Host-Microbiota Mutualism.

Authors:  Janelle S Ayres
Journal:  Cell       Date:  2016-06-02       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.